Rutherford Regional Health System Announces New Chief Executive Officer
Rutherfordton- August 2024- Rutherford Regional Health System, a Duke LifePoint facility, announces the appointment of Sue Shugart as chief executive officer (CEO),... Read more.
Oncoclínicas and Al Faisaliah Group Announce Strategic Partnership
Brazil- August 2024- Oncoclínicas is excited to announce its international expansion through a joint venture with Al Faisaliah Group, marking an entry into the... Read more.
Roche reacts to WHO’s global health emergency declaration on Mpox
Basel- August 2024- Roche announced that it is supporting the international response to the mpox global health emergency with its diagnostic tests developed for... Read more.
Australian Digital Health Agency welcomes first chief clinical nursing adviser
August 2024- The Australian Digital Health Agency is delighted to announce the appointment of Karen Booth as its inaugural Chief Clinical Adviser (Nursing). Ms Booth... Read more.
FDA Approves Updated mRNA COVID-19 Vaccines for Current Variants
Recently, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to... Read more.
KFSHRC Cuts Whole Genome Sequencing Costs by 67%
King Faisal Specialist Hospital & Research Centre (KFSHRC) has reduced the cost of whole genome sequencing (WGS) tests by 67% compared to previous technologies... Read more.
EU Approves TEPKINLY® for Relapsed/Refractory Follicular Lymphoma
NORTH CHICAGO, Ill.- AbbVie recently announced that the European Commission (EC) has granted conditional marketing authorization for TEPKINLY® (epcoritamab) as... Read more.
Fasenra Approved in China for Severe Eosinophilic Asthma
China’s National Medical Products Association (NMPA) has approved AstraZeneca’s Fasenra (benralizumab) for the maintenance treatment of patients aged 12... Read more.
Imfinzi Approved in the US for Resectable Lung Cancer Treatment
The US has approved AstraZeneca‘s Imfinzi (durvalumab) combined with chemotherapy to treat adult patients with resectable early-stage (IIA-IIIB) non-small... Read more.
Gavi’s Mpox Emergency Statement
Geneva– Gavi, the Vaccine Alliance continues to be deeply concerned about the escalating mpox emergency on the African continent. We welcome recently announced... Read more.
